Treating Periodontal Infection: Effects on Glycemic
關鍵詞
抽象
描述
There is compelling epidemiological and clinical evidence to suggest that periodontal infection adversely affects glycemic control in people with type 2 diabetes mellitus. The purpose of this pilot project is to obtain important preliminary data necessary to support design of a full scale, multi-center randomized clinical trial (RCT) to evaluate the effect of treating periodontal infection on glycemic control in individuals with type 2 diabetes mellitus. This current project involves treating periodontal infection to obtain estimates of changes and the variability of those changes over time in the established primary endpoint, hemoglobin A1c (HbA1c). This project will also explore use of several potential secondary endpoints including levels of periodontitis and glucose metabolism-related inflammatory mediators (TNF-alpha, IL-1-beta, IL-6), serum cholesterol, triglyceride and lipids. Subjects are randomly assigned to 1 of three possible groups for comprehensive periodontal examination, specimen collection, mechanical periodontal therapy and oral systemic antibiotics or placebo, and regular follow-up evaluations and site-specific mechanical periodontal therapy, at 3-month intervals, for approximately 15 months. Two groups receive ultrasonic scaling with local anesthesia (as needed), local antimicrobial treatment with povidone-iodine irrigation, and an oral systemic antibiotic (either doxycycline or metronidazole) at the initial treatment visit. The third group ("controls") receives a placebo and supra-gingival oral prophylaxis and ultrasonic removal of supra-gingival calculus with water irrigation at the initial treatment visit. At the 9-month follow-up visit, "controls" receive sub-gingival ultrasonic scaling with povidone-iodine irrigation.
Results from this pilot project will be used as preliminary data to support design of an immediate follow-up proposal to NIH/NIDCR for funding a multi-center RCT to evaluate the effect of treating periodontal infection on glycemic control in type 2 diabetes. If results from the full scale clinical trial provide evidence that treating periodontal infection contributes to improved glycemic control, then diagnosis and treatment of periodontal infection in subjects with type 2 diabetes could be substantiated as an important component in management of diabetes.
日期
| 最後驗證: | 06/30/2017 |
| 首次提交: | 06/04/2001 |
| 提交的預估入學人數: | 06/05/2001 |
| 首次發布: | 06/06/2001 |
| 上次提交的更新: | 07/13/2017 |
| 最近更新發布: | 07/18/2017 |
| 實際學習開始日期: | 10/16/2001 |
| 預計主要完成日期: | 09/02/2004 |
| 預計完成日期: | 09/02/2004 |
狀況或疾病
干預/治療
Procedure: Supra-gingival scaling and placebo
Procedure: Subgingival scaling and metronidazole
Procedure: Subgingival scaling and doxycycline
相
手臂組
| 臂 | 干預/治療 |
|---|---|
| Active Comparator: Supra-gingival scaling and placebo This group receives a placebo (instead of systemic antibiotic), supra-gingival oral prophylaxis, and ultrasonic removal of supra-gingival calculus with water irrigation at the initial treatment visit. At the 9-month follow-up visit, this group will receive sub-gingival ultrasonic scaling with povidone-iodine irrigation.
This group also receives regular follow-up evaluations and site-specific mechanical periodontal therapy, at 3-month intervals, for approximately 15 months. | Procedure: Supra-gingival scaling and placebo Included in arm/group description. |
| Experimental: Subgingival scaling and metronidazole This group receives ultrasonic scaling with local anesthesia (as needed), local antimicrobial treatment with povidone-iodine irrigation, and metronidazole as an oral systemic antibiotic at the initial treatment visit.
This group also receives regular follow-up evaluations and site-specific mechanical periodontal therapy, at 3-month intervals, for approximately 15 months. | Procedure: Subgingival scaling and metronidazole Included in arm/group description. |
| Experimental: Subgingival scaling and doxycycline This group receives ultrasonic scaling with local anesthesia (as needed), local antimicrobial treatment with povidone-iodine irrigation, and doxycycline as an oral systemic antibiotic at the initial treatment visit.
This group also receives regular follow-up evaluations and site-specific mechanical periodontal therapy, at 3-month intervals, for approximately 15 months. | Procedure: Subgingival scaling and doxycycline Included in arm/group description. |
資格標準
| 有資格學習的年齡 | 18 Years 至 18 Years |
| 有資格學習的性別 | All |
| 接受健康志願者 | 是 |
| 標準 | Inclusion Criteria - Subjects must be 18 years of age or older, - have at least six natural teeth, - have established periodontal disease (established at the screening examination), - have a history of type 2 diabetes of at least six months with HbAlc > 7.1%. Exclusion Criteria - Subjects will be excluded from the study if they are presently under the care of a periodontist; - have had antibiotic treatment within the previous three months; - have conditions that require antibiotic prophylaxis for dental treatment; - have allergies to iodine, doxycycline, metronidazole, or chlorhexidine; - have blood dyscrasias; - are pregnant or breast feeding; - have severe cognitive or communication impairment; - have a cardiac pacemaker; - are under cancer chemotherapy; - are medically unstable or have a life expectancy of less than two years; - are currently taking disulfiram, phenobarbital, lithium, terfenadine, astemizole, or warfarin; - or are out of town or otherwise unavailable for more than three consecutive months of the year. |
